|
J Biol Chem, Vol. 273, Issue 6, 3528-3534, February 6, 1998
Loss of Cellular K+ Mimics Ribotoxic Stress
INHIBITION OF PROTEIN SYNTHESIS AND ACTIVATION OF THE STRESS
KINASES SEK1/MKK4, STRESS-ACTIVATED PROTEIN KINASE/c-Jun
NH2-TERMINAL KINASE 1, AND p38/HOG1 BY PALYTOXIN*
Mihail S.
Iordanov and
Bruce E.
Magun
From the Department of Cell and Developmental Biology, Oregon
Health Sciences University, Portland, Oregon 97201
 |
ABSTRACT |
The tumor promoter palytoxin has been found to
activate the stress-activated protein kinase/c-Jun
NH2-terminal kinase 1 (SAPK/JNK1), and it also
potentiates, as demonstrated here, the p38/HOG1 mitogen-activated protein kinase and the upstream activator of SAPK/JNK1, SEK1/MKK4. In
search of possible mechanisms for both the cytotoxicity and the
activation of stress kinases by palytoxin, we found that palytoxin is a
potent inhibitor of cellular protein synthesis. The inhibition of
translation by palytoxin does not result from its direct binding to the
translational apparatus. We have previously demonstrated that ribotoxic
stressors (Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh,
T.-H., Pearson, J. A., Chen, S. L.-Y., and Magun, B. E. (1997) Mol. Cell. Biol. 17, 3373-3381) signal the
activation of SAPK/JNK1 by binding to or covalently modifying 28 S rRNA
in ribosomes that are active at the time of exposure to the stressor. Palytoxin acted as a ribotoxic stressor, inasmuch as it required actively translating ribosomes at the time of exposure to activate SAPK/JNK1. Palytoxin has been shown to augment ion fluxes by binding to
the Na+/K+-ATPase in the plasma membrane of
cells. To determine whether altered fluxes of either Na+ or
K+ could be responsible for the effects of palytoxin on
translation and on activation of SAPK/JNK1, cells were exposed to
palytoxin in modified culture medium in which a major portion of the
Na+ was replaced by either K+ or by
choline+. The substitution of Na+ by
K+ strongly inhibited the ability of palytoxin both to
inhibit protein translation and to activate SAPK/JNK1, whereas the
substitution of Na+ by choline+ did not. These
results suggest that palytoxin-induced efflux of cellular
K+ mimics ribotoxic stress by provoking both translational
inhibition and activation of protein kinases associated with cellular
defense against stress.
 |
INTRODUCTION |
Palytoxin is a non-peptide water-soluble marine toxin that is a
potent tumor promoter in the mouse skin carcinogenesis model (2-4).
Many tumor-promoting compounds that are effective in the skin of
carcinogen-initiated mice also produce an inflammatory reaction
(5-15). Inflammatory mediators such as interleukin-1 (IL-1)1 and tumor necrosis
factor- are potent activators of stress kinases such as SAPK/JNK1
and p38/HOG1 (for a review, see Ref. 16). Kuroki et al. (17)
have shown that Swiss 3T3 cells exposed to concentrations of palytoxin
as low as 0.1 nM display an abundant activation of the
stress-activated kinase SAPK/JNK1. Stimulation of SAPK/JNK1 has been
shown to lead to activation of AP-1, a dimeric transcription factor
composed of Jun (c-Jun, JunB, JunD) and Fos (c-Fos, FosB, Fra-1, Fra-2)
family members (for a review, see Ref. 18). SAPK/JNK1 phosphorylates
c-Jun at serines 63 and 73 in its NH2 terminus, thereby
increasing the transcription activating potential of AP-1 (19, 20).
Stimulation of SAPK/JNK1 also leads to the phosphorylation and
activation of the transcription factor Elk-1 (21, 22), which operates
on the regulatory region of c-fos (for reviews, see Refs. 23
and 24), and to the phosphorylation of activating transcription
factor-2 (25, 26), which, as an activating transcription factor-2/c-Jun
heterodimer, operates on the promoter of c-jun (27). Thus,
SAPK/JNK1 increases AP-1 activity in the nucleus by activating
pre-existing AP-1 complexes and by transcriptionally inducing the
expression of the components of AP-1, c-Jun, and c-Fos.
The cellular effects of palytoxin, which include ionic disequilibria
(28-30), increased production of prostaglandins from arachidonic acid
(31-36), and alterations in the affinity of the EGF receptor (37-39),
have been attributed to the ability of palytoxin to bind to the
Na+/K+-ATPase situated in the plasma membrane.
Direct binding of palytoxin to the
Na+/K+-ATPase, also known as the sodium pump,
transforms the pump into a permanently open ion channel that permits
the outward flux of K+ and the inward flux of
Na+ and that is independent of ATP hydrolysis (28-30).
Conclusive demonstration that palytoxin acts through the sodium pump
has come from heterologous expression of the sodium pump in
Saccharomyces cerevisiae, which lose intracellular
K+ following exposure to palytoxin (29, 30).
Recently, we reported on the identification of the 28 S ribosomal RNA
as a specific sensor for stress induced by a subset of agents that
inhibit protein synthesis (1). Some inhibitors of translation are
strong activators of SAPK/JNK1, whereas other equally effective
inhibitors of translation are unable to activate SAPK/JNK1. The
translational inhibitors that activated SAPK/JNK1, termed ribotoxic
stressors (1), either bind to the 28 S rRNA in the peptidyl transferase
center (40) (e.g. anisomycin and blasticidin S) or cause
specific damage to 28 S rRNA (e.g. ricin A chain and
-sarcin) within a conserved loop involved in binding of the
elongation factors EF-1 and EF-2 (for a review, see Ref. 41).
Activation of SAPK/JNK1 and of its upstream activator SEK1/MKK4 by this
group of ribotoxins can occur only when ribosomes are actively
translating at the time of exposure to the ribotoxic stressor. Prior
inhibition of translation by nonactivating agents such as diphtheria
toxin, T-2 toxin, pactamycin, or emetine for as little time as 2 min
abrogate the ability of the ribotoxic stressors, but not of IL-1 or
osmotic stress, to stimulate SAPK/JNK1 activity. We concluded that the
sensors for ribotoxic damage are ribosomes, which can transduce signals
that activate SEK1/MKK4 and SAPK/JNK1 only when they are
translationally active at the time of induced ribotoxicity. Although
many stress signals ultimately converge to activate the stress kinases,
signals arising during ribotoxicity are initially conveyed through a
pathway distinct from those used by IL-1 and osmotic stress (1). The
transduction of stress signals through ribosomes is a feature that
eukaryotes share with prokaryotes, whose ribosomes respond to some
translational inhibitors by recapitulating cellular responses
characteristic of either heat shock or cold shock (42).
In the experiments described here, we found that, like ribotoxic
stressors, palytoxin potently inhibited protein synthesis in the
concentration range that leads to activation of the stress kinases
SEK1/MKK4, SAPK/JNK1, and p38/HOG1. Similar to ribotoxic stressors, the
ability of palytoxin to activate SAPK/JNK1 depended on the presence of
actively translating ribosomes at the time of exposure to palytoxin.
However, unlike ribotoxic stressors, palytoxin did not inhibit protein
synthesis as a consequence of direct binding to the translational
apparatus. To determine whether the effects of palytoxin on translation
and SAPK/JNK1 activation resulted from altered ionic fluxes, a major
portion of the Na+ in the culture medium was replaced by
either K+ or choline+. The substitution of
Na+ by K+, but not by choline+,
inhibited the ability of palytoxin both to inhibit protein translation and to activate SAPK/JNK1, suggesting that the efflux of cellular K+ may be responsible for both translational inhibition and
activation of SAPK/JNK1. Thus, loss of K+ from stressed
cells may lead to the activation of stress kinases through
ribosome-mediated signaling.
 |
EXPERIMENTAL PROCEDURES |
Chemicals, Cytokines, and Ribotoxins--
Anisomycin, emetine,
D-sorbitol, and choline were from Sigma. IL-1
(recombinant mouse) was from Genzyme (Cambridge, MA). Palytoxin was
from Calbiochem. Anisomycin, emetine, and palytoxin were dissolved in
(H3C)2SO. In all the cases when
(H3C)2SO was used as a vehicle, corresponding
control cells received the same amount of the vehicle alone (typically
not more than 0.2% (v/v)). D-Sorbitol was dissolved in
Dulbecco's modified Eagle's medium (DMEM) as a 3 M stock
solution. All radiochemicals were from NEN Life Science Products.
Cell Culture--
Rat-1 cells were maintained as described
previously (43). The derivative cell line FC2-Rat1 has been
described by Rodland et al. (44). All experiments presented
here were performed using confluent, quiescent cultures obtained
through serum deprivation for typically 24 h. DMEM and MEM were
from Life Technologies, Inc.
Immunoprecipitation of SAPK/JNK1 and Extracellular
Signal-regulated Kinase and Immunocomplex Kinase Assays--
All
immunoprecipitations and immunocomplex kinase reactions were performed
as described for SAPK/JNK1 in Ref. 1. For immunoprecipitation of
SAPK/JNK1, the antibody sc-474 was used, and for immunoprecipitation of
extracellular signal-regulated kinase 1, the antibody sc-93-G was used
(both from Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Western Blot Analysis of SEK1/MKK4 Phosphorylation--
The
analysis of threonine 223 phosphorylation of SEK1/MKK4 was performed
with the antibody 9151S, and the analysis of tyrosine 182 phosphorylation of p38/HOG1 was performed with the antibody 9211S (both
from New England BioLabs Inc., Beverly, MA) as described in Ref. 1.
Measurement of Protein Synthesis--
Incorporation of
[3H]leucine was performed as described in Ref. 1.
Determination of protein synthesis using FC2-Rat1 cells and
a chloramphenicol acetyltransferase (CAT) assay has been described by
Rodland et al. (44). The measurement of luciferase mRNA
translation was performed with the Rabbit Reticulocyte Lysate System
(catalog number L4960) as described by the manufacturer (Promega,
Madison, WI).
Measurement of Na+/K+-ATPase
Activity--
The activity of the
Na+/K+-ATPase in membranal preparations from
Rat-1 cells was determined as described by Brotherus et al. (51) with modifications. Briefly, S100 microsomal pellets (20 µg of
total protein/experimental point) were resuspended in 0.6 ml of assay
solution (pH 7.2; 0.6 mM EGTA, 156 mM NaCl, 24 mM KCl, 3.6 mM MgCl2, 3.6 mM ATP, 60 mM imidazole, 10 mM
Na3N; with or without 0.5 mM ouabain) in the
presence of varying concentrations of palytoxin. After 60 min of
incubation at 37 °C, the reactions were stopped by the addition of
1.5 ml of ice-cold stopping solution (made by the sequential addition
on ice of 21.3 ml of 1 M HCl, 18.3 ml of H2O,
1.29 g of L-ascorbic acid, 2.13 ml of 10% ammonium molybdate, and 3.3 ml of 20% SDS). After 10 min of incubation on ice,
the color development was achieved by the addition of 1.5 ml of a
solution containing 2% (w/v) sodium meta-arsenite, 2%
(w/v) sodium citrate, and 2% (v/v) glacial acetic acid. After incubation for 10 min at room temperature, the absorption of the samples was measured at 850 nm, and the amount of Pi in
each sample was determined using a standard containing 50 µM Na3PO4.
PhosphorImager and Statistical Analyses--
The quantification
of 32PO43 transferred from
ATP onto GST-Elk-1 in experiments measuring SAPK/JNK1 kinase activity
was performed using the PhosphorImager apparatus and the IPLab
GelTM software from Molecular Dynamics (Sunnyvale, CA). Statistical
analyses were performed using the StatViewTM software from Abacus
Concepts, Inc. (Berkeley, CA).
 |
RESULTS |
Activation of SAPK/JNK1, SEK1/MKK4, and p38/HOG1 by
Palytoxin--
The addition of palytoxin to serum-deprived Rat-1 cells
potently induced the activation of SAPK/JNK1 when examined 30 min later
(Fig. 1, A and B).
As reported previously by Kuroki et al. (17), the ability of
palytoxin to activate SAPK/JNK1 was biphasic. At concentrations greater
than 1 nM, cells displayed a decreased responsiveness to
palytoxin; concentrations of palytoxin greater than 10 nM
were ineffective in activating SAPK/JNK1.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Palytoxin-induced inhibition of protein
synthesis and activation of the stress kinases SEK1/MKK4, SAPK/JNK1,
and p38/HOG1. A, activation of SAPK/JNK1 and phosphorylation
of SEK1/MKK4 and p38/HOG1 following treatment of Rat-1 cells with
palytoxin. Rat-1 cells (3 × 106) were serum-deprived
in DMEM for 24 h prior to stimulation with palytoxin
concentrations as shown. Cells were harvested in lysis buffer 30 min
after palytoxin addition, and the activity of SAPK/JNK1 was determined
in immunocomplex assays using an anti-SAPK/JNK1 antibody to precipitate
SAPK/JNK1 and using GST-Elk-1 recombinant protein to serve as a
substrate for phosphorylation (see "Experimental Procedures"). The
phosphorylation states of SEK1/MKK4 and p38/HOG1 were assessed in
Western blots using antibodies that recognize the respective
phosphorylation sites associated with activation (see "Experimental
Procedures"). B, effect of varying concentrations of
palytoxin on Na+/K+-ATPase activity, on
[3H]leucine incorporation and on SAPK/JNK1 activity. For
the Na+/K+-ATPase activity, membranes isolated
from Rat-1 cells (20 µg of total protein) were incubated in an assay
solution (see "Experimental Procedures") with the indicated
concentrations of palytoxin, in the presence or in the absence of 0.5 M ouabain at 37 °C. Sixty min later, the reactions were
stopped (see "Experimental Procedures"), and the degree of ATP
hydrolysis was determined as described under "Experimental
Procedures." The activity of the
Na+/K+-ATPase (defined as the difference
between the total ATPase activities without and with ouabain) in the
absence of palytoxin (indicated as 100% in the graph) was 17 µmol of
hydrolyzed ATP/1 µg of protein/1 h. The values for SAPK/JNK1 activity
were determined following quantitative PhosphorImager analysis of the
data in A (above). The effect of palytoxin on
[3H]leucine incorporation into acid-insoluble material
was determined in serum-deprived Rat-1 cells that were pulse-labeled
with [3H]leucine (1 µCi/ml) in DMEM from 15 to 30 min
following the addition of palytoxin. C, palytoxin-induced
inhibition of CAT mRNA translation in FC2-Rat1 cells.
Serum-deprived cells were stimulated for 2 h with EGF (40 ng/ml)
in the presence of cycloheximide (25 µg/ml). Thereafter, both EGF and
cycloheximide were removed from the medium by extensive washout
(indicated as release, t = 0 min). The
accumulation of CAT protein was monitored by measuring CAT activity 0, 60, 90, and 120 min after the release. Palytoxin (1 nM) was
applied 60 min after the release (arrow). Squares
represent CAT activity in cells treated at 60 min with solvent alone;
circles represent CAT activity in the palytoxin-treated
cells. S.D. was obtained from experimental points in triplicate.
|
|
SEK1/MKK4 is a kinase directly responsible for activation of SAPK/JNK1
(45-47). Palytoxin showed the same dose dependence in causing the
phosphorylation of SEK1/MKK4 at threonine 223, an event indicative of
the activation of this kinase (48) (Fig. 1A). These data
suggest that activation of SAPK/JNK1 is mediated by kinase-directed
signals generated upstream of SEK1/MKK4. Palytoxin showed a similar
dose dependence in the activation of p38/HOG1, a member of the
proline-directed stress kinases that bears functional and structural
homology to SAPK/JNK1 (Fig. 1A). As previously reported,
palytoxin did not induce the activation of the MAP kinase extracellular
signal-regulated kinase 1 (data not shown).
Translational Inhibition by Palytoxin--
Previously we reported
that some adverse agents that activate SAPK/JNK1 require ribosomes
actively engaged in translation at the the moment of exposure to do so,
while simultaneously inhibiting protein synthesis. These agents were
termed ribotoxic stressors (1). To determine if it could be acting as a
ribotoxic stressor, palytoxin was tested for its ability to inhibit the
incorporation of [3H]leucine into proteins in Rat-1
cells. Indeed, palytoxin inhibited the incorporation of
[3H]leucine in a dose-dependent manner (Fig.
1B). The ability of palytoxin to both activate stress
kinases (Fig. 1, A and B) and repress
[3H]leucine incorporation (Fig. 1B) became
apparent at concentrations of the toxin that were inhibitory for the
Na+/K+-ATPase in membranal preparations
isolated from Rat-1 cells (Fig. 1B; see "Experimental
Procedures," and see below). Because palytoxin is known to act on
membrane-associated functions, we considered the possibility that
transport of [3H]leucine into cells is impaired following
exposure to palytoxin. To avoid this potential complication, we applied
a method for measuring cellular protein synthesis that is independent
of transport and incorporation of amino acids. A derivative of the
parental Rat-1 cells, the cell clone FC2-Rat1 bears a
stably integrated CAT reporter gene under the control of a 1-kilobase
promoter sequence of the human c-fos gene (44). The
expression of CAT mRNA is kept at very low levels in quiescent
cells, but it can be induced up to 100-fold upon stimulation with EGF
in the presence of cycloheximide (not shown). The presence of
cycloheximide prevents the translation of the CAT mRNA into CAT
protein. Release from the cycloheximide-induced translational arrest
(Fig. 1C, t = 0 min) allows efficient
translation of the accumulated CAT mRNA. The accumulation of CAT
protein increased linearly within 2 h following the washout of
cycloheximide as measured by a CAT activity assay (Fig. 1C).
Since EGF was also removed from the medium together with cycloheximide,
the increase of CAT activity resulted solely from translation of the
CAT mRNA that had accumulated before the washout. Treatment of the
cells with palytoxin 60 min after the release from translational arrest resulted in a substantial decrease in CAT activity detectable both 30 and 60 min after the addition of palytoxin (Fig. 1C). We
therefore conclude that exposure of cells to palytoxin indeed interferes with the process of translation.
Many inhibitors of protein synthesis alter ribosomal activity by
binding directly to ribosomes (49, 50). The actions of these inhibitors
are readily detected following their addition to reticulocyte lysates
that contain ribosomes and all of the necessary ingredients to allow
the initiation and elongation of translation in vitro. To
test whether palytoxin could inhibit protein synthesis by directly
modifying the functionality of ribosomes in vitro, we added
palytoxin to a reticulocyte lysate preparation engaged in protein
synthesis (Fig. 2). The addition to the
reticulocyte lysate of mRNA for luciferase reporter protein (Fig.
2, t = 0 min) and subsequent monitoring of luciferase
activity demonstrated the effectiveness of the lysate in promoting both
initiation and elongation. The addition of the elongation inhibitor
emetine at 8 min completely blocked the further accumulation of
luciferase activity. Palytoxin (30 nM) was completely
ineffective in inhibiting translation of luciferase when added prior to
the addition of luciferase mRNA. These data demonstrate that
neither translational initiation nor translational elongation were
affected by the addition of palytoxin to a cell-free translational
system. We therefore conclude that the inhibition of translation
induced by palytoxin in vivo is unlikely to be mediated by
direct interaction between palytoxin and the translational
apparatus.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of palytoxin on the translation of
luciferase mRNA in a rabbit reticulocyte lysate assay. The
mRNA for luciferase (0.5 µg), palytoxin (30 nM), or
solvent (H3C)2SO was added at t = 0 min. Emetine (10 µg/ml) was added at t = 8 min.
At designated times, aliquots of the lysate were withdrawn and analyzed
for luciferase activity. The assay was performed with a reticulocyte lysate kit, supplemented with amino acids, as described by the manufacturer (Promega).
|
|
Translational Inhibitors Interfere with Palytoxin-induced
Activation of SAPK/JNK1--
The demonstration that palytoxin is a
potent in vivo inhibitor of protein synthesis prompted us to
test whether palytoxin shares some of the properties of ribotoxic
stressors, which both activate SAPK/JNK1 and inhibit protein
translation (1). We previously showed that the activation of SAPK/JNK1
by ribotoxic stressors is rapidly suppressed in cells whose protein
synthesis had been previously blocked by translational inhibitors that
are incapable of activating SAPK/JNK1 (1). Mediation of
SAPK/JNK1-activating signals could only occur in ribosomes that are
active at the time of exposure of ribotoxic stressors. The following
experiments test whether activation of SAPK/JNK1 by palytoxin similarly
depends on the presence of active ribosomes.
Pretreatment of cells for 15 min with emetine, an inhibitor of
translational elongation, suppressed the palytoxin-induced activation
of SAPK/JNK1 measured 30 min after the addition of palytoxin (Fig.
3, lanes 2 and 3).
A similar suppression of SAPK/JNK1 activation was observed when cells
were preincubated with pactamycin, a specific inhibitor of
translational initiation (data not shown). Emetine also suppressed the
activation of SAPK/JNK1 by the ribotoxic stressor anisomycin (1) (Fig.
3, lanes 4 and 5), but not by sorbitol, an
osmotic stressor that does not act through ribosomal toxicity (1) (Fig.
3, lanes 6 and 7).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibition of the palytoxin-induced
activation of SAPK/JNK1 by pretreatment of Rat-1 cells with
emetine. Serum-deprived Rat-1 cells were left untreated
(lanes 1, 2, 4, and 6) or
were exposed to emetine (lanes 3, 5,
7, and 8) for 15 min prior to the addition of
palytoxin (1 nM; lanes 2 and 3),
anisomycin (10 µg/ml; lanes 4 and 5), or
sorbitol (600 mM; lanes 6 and 7).
Cells were harvested in lysis buffer 30 min later, and SAPK/JNK1
activity was determined by immunocomplex assay using GST-Elk-1 as
substrate. Co, control cells. E, emetine-treated
cells.
|
|
In studying the effects of ribotoxic stressors, we reported that
inhibiting protein translation by emetine as soon as 1 min prior to the
addition of anisomycin was sufficient to block transduction of the
signals that lead ultimately to activation of SAPK/JNK1 (1). This rapid
action of emetine was taken as evidence that prior inhibition of
translation by emetine was unlikely to exert its blockade of SAPK/JNK1
activation by blocking the synthesis of a protein with rapid decay
kinetics (1). The experiment presented in Fig.
4 similarly demonstrates that the
addition of emetine 1 min prior to the addition of palytoxin
substantially suppressed the activation of SAPK/JNK1. Emetine failed to
suppress palytoxin-induced activation of SAPK/JNK1 when emetine was
added 3 min after the addition of palytoxin. The ability of a
translational inhibitor to block palytoxin-induced signaling within
such a short time suggests that active ribosomes are necessary for
signal transduction and furthermore argues against the likelihood that
a protein with kinetics of rapid decay could explain the
emetine-induced block to SAPK/JNK1 activation. The inability of emetine
to inhibit SAPK/JNK1 signaling when added 3 min after the palytoxin
addition suggests that the critical ribosome-mediated events that are
required to transduce the signal have already occurred by 3 min. These
data demonstrate that, similar to ribotoxic stressors, palytoxin
requires the presence of active ribosomes at the time of addition to
activate SAPK/JNK1.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of emetine on the activation of
SAPK/JNK1 by palytoxin in Rat-1 cells. Graphic representation of
the data from immunocomplex kinase assays. Serum-deprived Rat-1 cells
were treated as follows (from left to right) with
the following: solvent alone; emetine (100 µg/ml) alone; palytoxin (1 nM) alone; or palytoxin under conditions of prior,
contemporaneous, or subsequent treatment with emetine as denoted in the
scheme (top). SAPK/JNK1 activity was determined 30 min after
the addition of palytoxin.
|
|
Effects of Palytoxin on Translation and Signaling in Media
Containing Modified [Na+], [K+], or
[Choline+]--
Several lines of evidence indicate that
the biological effects of palytoxin are mediated through its
interaction with the Na+/K+-ATPase (28-30).
The most convincing evidence derives from the introduction of a
mammalian Na+/K+-ATPase into yeast, which
demonstrated that palytoxin interacts directly with this molecule to
facilitate the simultaneous entry of Na+ and exit of
K+ from cells (29, 30). Since it appeared that the
ribotoxic activity of palytoxin could not be related to direct
interaction with the translational machinery, we tested whether the
ribotoxic actions of palytoxin could have resulted from ionic
disequilibria produced in cells as a consequence of poisoning of the
Na+/K+-ATPase. To test this possibility, we
conducted experiments in which 75% of the 154 mM NaCl
present in MEM culture medium was replaced by either KCl (116 mM KCl; K-MEM) or choline chloride (116 mM;
Cho-MEM). Experiments were conducted to determine whether the modified
isotonic MEM containing either K+ or choline+
would reduce the ability of palytoxin to inhibit protein synthesis or
to activate SAPK/JNK1. Cells were far more sensitive to inhibition of
protein synthesis by palytoxin in MEM, compared with K-MEM, which
shifted the dose-response curve 2 decades to the right (Fig. 5). By contrast, cells were 3-fold more
sensitive in Cho-MEM than in MEM. The ability of increased
extracellular K+, but not choline+, to diminish
substantially the ability of palytoxin to inhibit translation is
consistent with the conclusion that efflux of K+ may be
responsible for the effects of palytoxin. The inability of
extracellular choline+ to reduce the translational
inhibition by palytoxin is consistent with the notion that influx of
Na+ is unlikely to be the cause of the effects of
palytoxin.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of palytoxin on the incorporation of
[3H]leucine following replacement of Na+ in
MEM by K+ or choline+. Serum-deprived
Rat-1 cells were incubated in standard MEM (containing 154 mM Na+) or in MEM containing 38 mM
Na+ and 116 mM of either K+ (K-MEM)
or choline+ (Cho-MEM). After the addition of varying
concentrations of palytoxin, cells were pulse-labeled with 5 µCi/ml
[3H]leucine from 10 to 20 min. S.D. was obtained from
experimental points in triplicate.
|
|
To determine whether the potential of palytoxin to inhibit protein
translation in MEM, K-MEM, or Cho-MEM correlates with the potential to
activate SAPK/JNK1, we exposed cells to standard or modified MEM for 30 min prior to the addition of palytoxin. The results demonstrate that,
compared with MEM, K-MEM suppressed the ability of palytoxin to
activate SAPK/JNK1, and that cells incubated in Cho-MEM showed a more
pronounced activation of SAPK/JNK1 at equivalent palytoxin
concentrations (Fig. 6A). The
cells in K-MEM were still capable of responding to other ribotoxic and nonribotoxic stressors, since the activity of SAPK/JNK1 was strongly elevated in cells exposed to K-MEM containing anisomycin (a ribotoxic stressor), sorbitol, or IL-1 . (Fig. 6B). These data
demonstrate that, in addition to its diminished ability to inhibit
protein translation in K-MEM, palytoxin was also unable to activate
SAPK/JNK1. These data also demonstrated that the inability of palytoxin
to activate SAPK/JNK1 in K-MEM does not result from the general
inhibition by K-MEM of pathways leading to SAPK/JNK1 activation.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of palytoxin and other agents on
SAPK/JNK1 activation following the replacement of Na+ in
MEM by K+ or choline. A, effect of palytoxin on
SAPK/JNK1 activation. Serum-deprived Rat-1 cells were incubated in MEM,
K-MEM, or Cho-MEM (as in Fig. 5) for 10 min prior to the addition of
varying doses of palytoxin. Thirty min later, cells were harvested, and
the lysate was analyzed for activated SAPK/JNK1 by an immunocomplex assay. The PhosphorImager data is displayed in the lower
part; the graphic representation of this data is displayed in the
upper part. B, effectiveness of several agents to
activate SAPK/JNK1 following replacement of Na+ in MEM by
K+ or choline+. The experiment is similar to
the one presented in A. Cells were incubated in MEM, K-MEM,
or Cho-MEM and exposed to palytoxin (0.1 nM), anisomycin
(10 µg/ml), sorbitol (600 mM) for 30 min or to IL-1
(25 ng/ml) for 10 min prior to harvesting and analysis of SAPK/JNK1
activation by the immunocomplex assay.
|
|
We next tested whether cells exposed to palytoxin in K-MEM were capable
of responding to the toxin when transferred from K-MEM to standard MEM
(Fig. 7). The increase in SAPK/JNK1
activity in cells exposed for 30 min to 0.1 nM palytoxin in
standard MEM was inhibited in K-MEM (Fig. 7, lanes B and
D). When cells incubated for 30 min in K-MEM containing
palytoxin were rinsed with palytoxin-free K-MEM and transferred to
standard MEM without palytoxin (Fig. 7, lane F), SAPK/JNK1
activity was increased to at least the same levels achieved by
palytoxin in standard MEM. These data suggest that K-MEM impeded the
transduction of a signal generated by palytoxin; shifting cells to
standard MEM supplied the conditions necessary to complete transduction
of the signal that leads to the activation of SAPK/JNK1. The increase
in SAPK/JNK1 activity following the exchange of K-MEM for
standard MEM again suggests that K+ efflux may be
responsible for initiating the activation of SAPK/JNK1 in
palytoxin-treated cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Activation of SAPK/JNK1 when Rat-1 cells
incubated in K-MEM plus palytoxin are postincubated in MEM without
palytoxin. A, cells were incubated in MEM for 75 min.
B, cells were incubated in MEM for 15 min prior to the
addition of palytoxin for an additional 60 min. C, cells
were incubated in K-MEM for 75 min. D, cells were incubated
in K-MEM for 15 min prior to the addition of palytoxin. E,
cells were incubated in K-MEM for 45 min; cells were then rinsed several times in K-MEM and placed into fresh MEM for an additional 30 min. F, cells were incubated in K-MEM for 15 min prior to
the addition of palytoxin. At 45 min, the medium was removed, cells were rinsed several times in palytoxin-free K-MEM, and fresh MEM was
added for an additional 30 min. All cells were harvested at 75 min, and
cell lysates were analyzed for activation of SAPK/JNK1 by an
immunocomplex assay. Palytoxin (PT) was added at 0.1 nM.
|
|
 |
DISCUSSION |
The ability of palytoxin to both inhibit protein synthesis and
stimulate SAPK/JNK1 activity (Fig. 1) led us to investigate whether
palytoxin acts as a ribotoxic stressor. Previously identified ribotoxic
stressors share the following characteristics: (i) they inhibit
translational elongation by interacting directly with 28 S rRNA in the
region of the peptidyl transferase center or the S/R loop; (ii) they
rapidly induce the activation of the stress kinases SEK1/MKK4,
SAPK/JNK1, and p38/HOG1; and (iii) they induce the activation of stress
kinases only in cells that contain actively translating ribosomes (1).
Other nonribotoxic stressors that activate stress kinases, such as
proinflammatory cytokines and osmotic stress, are distinguished from
ribotoxic stressors by their ability to induce signaling to the stress
kinases even in the absence of translationally active ribosomes.
Although experiments demonstrated that palytoxin was ineffective as a
translational inhibitor when added directly to actively translating
ribosomes in vitro (Fig. 2), palytoxin nevertheless required
translating ribosomes to transduce signals that activate SAPK/JNK1
in vivo. The rapid inhibition of SAPK/JNK1 activation by
emetine, which substantially blocked the activation when added just 1 min prior to palytoxin (Fig. 3), was also observed when emetine was
added just prior to ribotoxic stressors such as anisomycin and ricin (1). The rapid action of emetine in this context suggests that actively
translating ribosomes are required for palytoxin-initiated signals to
be transduced to the kinase(s) upstream of SEK1/MKK4 and SAPK/JNK1.
That cells exposed to palytoxin became refractory to emetine when
emetine was added 3 min after palytoxin suggests that the critical
events of ribosome-mediated transduction are completed by 3 min. A
similar time course was observed for anisomycin (1).2 Since the effects of
palytoxin include translational inhibition, it appears plausible that
the signaling is self-terminating and that the involvement of ribosomes
in this process is completed within this short period of time.
The binding of palytoxin to Na+/K+-ATPase
results in an "open" ion channel that permits free passage of
Na+ and K+ into or out of cells, depending on
the ion gradient on both sides of the cell membrane (28-30). Kuroki
et al. (17) reported that in Swiss 3T3 fibroblasts DMEM in
which Na+ was replaced by K+ suppressed the
ability of palytoxin to activate SAPK/JNK1; from these data they
concluded that palytoxin-activated Na+ influx was
responsible for the activation of SAPK/JNK1. Our data in Rat-1
fibroblasts are in agreement with those of Kuroki et al.
(17) and furthermore demonstrated that replacement of Na+
by K+ strongly suppressed the translational inhibition by
palytoxin (Figs. 5 and 6). However, neither SAPK/JNK1 activation nor
translational inhibition was diminished when Na+ was
replaced by choline+, a nonpenetrating cation used to
maintain osmotic balance, and in fact both SAPK/JNK1 activation and
translational inhibition were increased in the
choline+-containing medium. These data suggest that
palytoxin-induced efflux of K+, rather than influx of
Na+, was responsible for both SAPK/JNK1 activation and
translational inhibition. The inability of K-MEM to suppress the
activation of SAPK/JNK1 mediated by other agents such as anisomycin,
sorbitol, or IL-1 suggests that replacement of Na+ by
K+ did not generally inhibit the transduction of
stress-generated signals from other ribotoxic or nonribotoxic
stressors. Additionally, the activation of SAPK/JNK1 and suppression of
translation that occurred in palytoxin-treated cells following the
removal of K-MEM and replacement by palytoxin-free MEM demonstrates
that the exposure of cells to K-MEM did not impair the ability of the
cells to respond when placed in an appropriate ionic environment.
Palytoxin is the most potent nonproteinaceous toxin that has been
identified. Although the ability of palytoxin to alter cation fluxes
has been well documented, to date there has been no explanation for its
severe toxicity. The demonstration in this paper that palytoxin can
inhibit protein synthesis at picomolar concentrations (IC50 = 1 pM, Fig. 1B) places palytoxin among the most
potent translational inhibitors, and this may account for its potent toxicity.
 |
ACKNOWLEDGEMENTS |
We acknowledge the technical assistance of
Thanh-Hoai Dinh, Jennifer Magun, and Jean Pearson.
 |
FOOTNOTES |
*
This work was supported by U.S. Public Health Service Grants
CA-39360 and ES-08456.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Tel.: 503-494-7811;
Fax: 503-494-4253; E-mail: magunb{at}OHSU.edu.
1
The abbreviations used are: IL, interleukin;
SAPK/JNK, stress-activated protein kinase/c-Jun
NH2-terminal kinase; p38/HOG1, mammalian homolog of the
S. cerevisiae high osmolarity glycerol response kinase-1;
SEK1/MKK4, SAPK/extracellular signal-regulated kinase-1/mitogen-activated protein kinase kinase-4; AP-1, activator protein-1; GST-Elk-1, glutathione S-transferase/Elk-1 fusion
protein; MEM, modified Eagle's medium; EGF, epidermal growth
factor.
2
M. S. Iordanov, D. Pribnow, J. L. Magun, J. A. Pearson, T.-H. Dinh, and B. E. Magun, submitted for
publication.
 |
REFERENCES |
-
Iordanov, M. S.,
Pribnow, D.,
Magun, J. L.,
Dinh, T.-H.,
Pearson, J. A.,
Chen, S. L.-Y.,
Magun, B. E.
(1997)
Mol. Cell. Biol.
17,
3373-3381[Abstract]
-
Fujiki, H.,
Suganuma, M.,
Tahira, T.,
Yoshioka, A.,
Nakayasu, M.,
Endo, Y.,
Shudo, K.,
Takayama, S.,
Moore, R. E.,
Sugimura, T.
(1983)
Princess Takamatsu Symp.
14,
37-45[Medline]
[Order article via Infotrieve]
-
Fujiki, H.,
Suganuma, M.,
Nakayasu, M.,
Hakii, H.,
Horiuchi, T.,
Takayama, S.,
and Sugimura, T.
(1986)
Carcinogenesis
7,
707-710[Abstract/Free Full Text]
-
Wattenberg, E. V.,
Uemura, D.,
Byron, K. L.,
Villereal, M. L.,
Fujiki, H.,
Rosner, M. R.
(1989)
Cancer Res.
49,
5837-5842[Abstract/Free Full Text]
-
Scribner, J. D.,
and Boutwell, R. K.
(1972)
Eur. J. Cancer
8,
617-621
-
Segal, A.,
Van Duuren, B. L.,
Mate, U.,
Solomon, J. J.,
Seidman, I.,
Smith, A.,
Melchionne, S.
(1978)
Cancer Res.
38,
921-925[Abstract/Free Full Text]
-
Fischer, S. M.
(1980)
Arachidonic Acid Metabolism and Tumor Promotion, Martinus Nijhoff, Boston
-
Furstenberger, G.,
Berry, D. L.,
Sorg, B.,
and Marks, F.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
7722-7726[Abstract/Free Full Text]
-
McGaughey, C.,
and Jensen, J. L.
(1983)
J. Toxicol. Environ. Health
11,
467-474[Medline]
[Order article via Infotrieve]
-
Schoof, R. A.,
and Baxter, C. S.
(1986)
Int. J. Immunopharmacol.
8,
455-462[CrossRef][Medline]
[Order article via Infotrieve]
-
Lewis, J. G.,
and Adams, D. O.
(1987)
Carcinogenesis
8,
889-898[Abstract/Free Full Text]
-
Michiel, D. F.,
and Oppenheim, J. J.
(1992)
Semin. Cancer Biol.
3,
3-15[Medline]
[Order article via Infotrieve]
-
Martins-Green, M.,
Boudreau, N.,
and Bissell, M. J.
(1994)
Cancer Res.
54,
4334-4341[Abstract/Free Full Text]
-
Furstenberger, G.,
Csuk-Glanzer, B. I.,
Marks, F.,
Keppler, D.
(1994)
Carcinogenesis
15,
2823-2827[Abstract/Free Full Text]
-
Marks, F.,
Furstenberger, G.,
Heinzelmann, T.,
and Muller-Decker, K.
(1995)
Toxicol. Lett.
83,
907-917[CrossRef]
-
Kyriakis, J. M.,
and Avruch, J.
(1996)
BioEssays
18,
567-577[CrossRef][Medline]
[Order article via Infotrieve]
-
Kuroki, D. W.,
Bignami, G. S.,
and Wattenberg, E. V.
(1996)
Cancer Res.
56,
637-644[Abstract/Free Full Text]
-
Angel, P.,
and Karin, M.
(1991)
Biochim. Biophys. Acta
1072,
129-157[Medline]
[Order article via Infotrieve]
-
Hibi, M.,
Lin, A.,
Smeal, T.,
Minden, A.,
and Karin, M.
(1993)
Genes Dev.
7,
2135-2148[Abstract/Free Full Text]
-
Derijard, B.,
Hibi, M.,
Wu, I.-H.,
Barrett, T.,
Su, B.,
Deng, T.,
Karin, M.,
and Davis, R. J.
(1994)
Cell
76,
1025-1037[CrossRef][Medline]
[Order article via Infotrieve]
-
Whitmarsh, A. J.,
Shore, P.,
Sharrocks, A. D.,
Davis, R. J.
(1995)
Science
269,
403-407[Abstract/Free Full Text]
-
Cavigelli, M.,
Dolfi, F.,
Claret, F.-X.,
and Karin, M.
(1995)
EMBO J.
14,
5957-5964[Medline]
[Order article via Infotrieve]
-
Treisman, R.
(1994)
Curr. Opin. Genet. Dev.
4,
96-101[CrossRef][Medline]
[Order article via Infotrieve]
-
Treisman, R.
(1995)
EMBO J.
14,
4905-4913[Medline]
[Order article via Infotrieve]
-
Gupta, S.,
Campbell, D.,
Derijard, B.,
and Davis, R. J.
(1995)
Science
267,
389-393[Abstract/Free Full Text]
-
van Dam, H.,
Wilhelm, D.,
Herr, I.,
Steffen, A.,
Herrlich, P.,
and Angel, P.
(1995)
EMBO J.
14,
1798-1811[Medline]
[Order article via Infotrieve]
-
van Dam, H.,
Duyndam, M.,
Rottier, R.,
Bosch, A.,
de Vries-Smits, L.,
Herrlich, P.,
Zantema, A.,
Angel, P.,
van der Eb, A. J.
(1993)
EMBO J.
12,
479-487[Medline]
[Order article via Infotrieve]
-
Habermann, E.
(1989)
Toxicon
27,
1171-1187[Medline]
[Order article via Infotrieve]
-
Scheiner-Bobis, G.,
Meyer zu Heringdorf, D.,
Christ, M.,
and Habermann, E.
(1994)
Mol. Pharmacol.
45,
1132-1136[Abstract]
-
Redondo, J.,
Fiedler, B.,
and Scheiner-Bobis, G.
(1996)
Mol. Pharmacol.
49,
49-57[Abstract]
-
Ohuchi, K.,
Watanabe, M.,
Yoshizawa, K.,
Tsurufuji, S.,
Fujiki, H.,
Suganuma, M.,
Sugimura, T.,
and Levine, L.
(1985)
Biochim. Biophys. Acta
834,
42-47[Medline]
[Order article via Infotrieve]
-
Levine, L.,
Xiao, D. M.,
and Fujiki, H.
(1986)
Prostaglandins
31,
669-681[CrossRef][Medline]
[Order article via Infotrieve]
-
Levine, L.,
Xiao, D.,
and Fujiki, H.
(1986)
Carcinogenesis
7,
99-103[Abstract/Free Full Text]
-
Lazzaro, M.,
Tashjian, A., Jr.,
Fujiki, H.,
and Levine, L.
(1987)
Endocrinology
120,
1338-1345[Abstract/Free Full Text]
-
Aizu, E.,
Yamamoto, S.,
Nakadate, T.,
and Kato, R.
(1990)
Eur. J. Pharmacol.
182,
19-28[CrossRef][Medline]
[Order article via Infotrieve]
-
Levine, L.
(1991)
Prostaglandins
41,
7-19[CrossRef][Medline]
[Order article via Infotrieve]
-
Wattenberg, E. V.,
Fujiki, H.,
and Rosner, M. R.
(1987)
Cancer Res.
47,
4618-4622[Abstract/Free Full Text]
-
Wattenberg, E. V.,
McNeil, P. L.,
Fujiki, H.,
and Rosner, M. R.
(1989)
J. Biol. Chem.
264,
213-219[Abstract/Free Full Text]
-
Wattenberg, E. V.,
Byron, K. L.,
Villereal, M. L.,
Fujiki, H.,
Rosner, M. R.
(1989)
J. Biol. Chem.
264,
14668-14673[Abstract/Free Full Text]
-
Rodrigues-Fonseca, C.,
Amils, R.,
and Garrett, R. A.
(1995)
J. Mol. Biol.
247,
224-235[CrossRef][Medline]
[Order article via Infotrieve]
-
Wool, I. G.,
Glück, A.,
and Endo, Y.
(1992)
Trends Biochem. Sci.
17,
266-269[CrossRef][Medline]
[Order article via Infotrieve]
-
VanBogelen, R.,
and Neidhardt, F. C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
5589-5593[Abstract/Free Full Text]
-
Magun, B. E.,
and Rodland, K. D.
(1995)
Cell Growth Differ.
6,
891-897[Abstract]
-
Rodland, K.,
Wersto, R.,
Hobson, S.,
and Kohn, E.
(1997)
Mol. Endocrinol.
11,
281-291[Abstract/Free Full Text]
-
Sanchez, I.,
Hughes, R. T.,
Mayer, B. J.,
Yee, K.,
Woodgett, J. R.,
Avruch, J.,
Kyriakis, J. M.,
Zon, L. I.
(1994)
Nature
372,
794-798[Medline]
[Order article via Infotrieve]
-
Lin, A.,
Minden, A.,
Martinetto, H.,
Claret, F.-X.,
Lange-Carter, C.,
Mercurio, F.,
Johnson, G. L.,
Karin, M.
(1995)
Science
268,
286-290[Abstract/Free Full Text]
-
Derijard, B.,
Raingeaud, J.,
Barrett, T.,
Wu, I.-H.,
Han, J.,
Ulevitch, R. J.,
Davis, R. J.
(1995)
Science
267,
682-684[Abstract/Free Full Text]
-
Yan, M.,
Dai, T.,
Deak, J. C.,
Kyriakis, J. M.,
Zon, L. I.,
Woodgett, J. R.,
Templeton, D. J.
(1994)
Nature
372,
798-800[Medline]
[Order article via Infotrieve]
-
Pestka, S.
(1971)
Annu. Rev. Microbiol.
25,
487-562[CrossRef][Medline]
[Order article via Infotrieve]
-
Vazquez, D.
(1979)
Inhibitors of Protein Biosynthesis, Springer-Verlag, Berlin
-
Brotherus, J. R.,
Moller, J. V.,
and Jorgensen, P. L.
(1981)
Biochem. Biophys. Res. Commun.
100,
146-154[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. V. Wattenberg
Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C24 - C32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Korcheva, J. Wong, C. Corless, M. Iordanov, and B. Magun
Administration of Ricin Induces a Severe Inflammatory Response via Nonredundant Stimulation of ERK, JNK, and P38 MAPK and Provides a Mouse Model of Hemolytic Uremic Syndrome
Am. J. Pathol.,
January 1, 2005;
166(1):
323 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Laskin, D. E. Heck, and D. L. Laskin
The Ribotoxic Stress Response as a Potential Mechanism for MAP Kinase Activation in Xenobiotic Toxicity
Toxicol. Sci.,
October 1, 2002;
69(2):
289 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Iordanov, R. J. Choi, O. P. Ryabinina, T.-H. Dinh, R. K. Bright, and B. E. Magun
The UV (Ribotoxic) Stress Response of Human Keratinocytes Involves the Unexpected Uncoupling of the Ras-Extracellular Signal-Regulated Kinase Signaling Cascade from the Activated Epidermal Growth Factor Receptor
Mol. Cell. Biol.,
August 1, 2002;
22(15):
5380 - 5394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Iordanov, J. M. Paranjape, A. Zhou, J. Wong, B. R. G. Williams, E. F. Meurs, R. H. Silverman, and B. E. Magun
Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways
Mol. Cell. Biol.,
January 15, 2000;
20(2):
617 - 627.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. S. Iordanov and B. E. Magun
Different Mechanisms of c-Jun NH2-terminal Kinase-1 (JNK1) Activation by Ultraviolet-B Radiation and by Oxidative Stressors
J. Biol. Chem.,
September 3, 1999;
274(36):
25801 - 25806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. I. Shifrin and P. Anderson
Trichothecene Mycotoxins Trigger a Ribotoxic Stress Response That Activates c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase and Induces Apoptosis
J. Biol. Chem.,
May 14, 1999;
274(20):
13985 - 13992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Iordanov, D. Pribnow, J. L. Magun, T.-H. Dinh, J. A. Pearson, and B. E. Magun
Ultraviolet Radiation Triggers the Ribotoxic Stress Response in Mammalian Cells
J. Biol. Chem.,
June 19, 1998;
273(25):
15794 - 15803.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|